Glypican 3 as a novel marker for Hepatocellular carcinoma / Alice Saber Gerges ; Supervised Inas Ismail Raafat , Eman El-Ghroury , Mai Mahmoud Sherif

By:

Alice Saber Gerges

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Alice Saber Gerges , 2013Description: 180 P. : charts ; 25cmOther title:

الجليبكان 3 كدلالة جديدة للورم السرطانى بالكبد [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology Summary: Most of patients with HCC are diagnosed at a late stage. Therefore, the prognosis of HCC patients is generally very poor. Alpha.fetoprotein has been widelly used , but its sensitivity has not been satisfactory , in addition to its non-specific elevation innon malignant hepatic diseases. Glypican 3, this protein(GPC3) is over-expressed in HCC, and not in normal hepatocytes and non-malignant liver disease.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Date due	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.07.Ph.D.2013.Al.G (Browse shelf(Opens below))		Not for loan		01010110060985000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.07.Ph.D.2013.Al.G (Browse shelf(Opens below))	60985.CD	Not for loan		01020110060985000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.11.07.Ph.D.2012.Sh.R Real - time PCR assay of VKORC1 and CYP2C9 gene polymorphisms that affect warfarin response /	Cai01.11.07.Ph.D.2013.Ah.M Mex efflux pumps in MDR pseudomonas aeruginosa : Risk factors and detection /	Cai01.11.07.Ph.D.2013.Ah.M Mex efflux pumps in MDR pseudomonas aeruginosa : Risk factors and detection /	Cai01.11.07.Ph.D.2013.Al.G Glypican 3 as a novel marker for Hepatocellular carcinoma /	Cai01.11.07.Ph.D.2013.Al.G Glypican 3 as a novel marker for Hepatocellular carcinoma /	Cai01.11.07.Ph.D.2013.Al.Q Quantitative RT-PCR study of TAp73 and xNp73 in benign and malignant lymphoid lesions /	Cai01.11.07.Ph.D.2013.Al.Q Quantitative RT-PCR study of TAp73 and xNp73 in benign and malignant lymphoid lesions /	Next

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

Most of patients with HCC are diagnosed at a late stage. Therefore, the prognosis of HCC patients is generally very poor. Alpha.fetoprotein has been widelly used , but its sensitivity has not been satisfactory , in addition to its non-specific elevation innon malignant hepatic diseases. Glypican 3, this protein(GPC3) is over-expressed in HCC, and not in normal hepatocytes and non-malignant liver disease.

Issued also as CD

There are no comments on this title.

to post a comment.